Łukasz Obrycki Selected Research

Łukasz Obrycki Research Topics

3	Hypertension (High Blood Pressure) 01/2022 - 01/2021
1	Kidney Diseases (Kidney Disease) 04/2022
1	Arteriosclerosis 01/2022
1	Hypotension (Low Blood Pressure) 01/2022
1	White Coat Hypertension 01/2022
1	Hepatolenticular Degeneration (Wilson's Disease) 10/2021
1	Liver Cirrhosis (Hepatic Cirrhosis) 10/2021
1	Fibrosis (Cirrhosis) 10/2021
1	Fatty Liver 10/2021
1	Hypercalcemia (Milk Alkali Syndrome) 01/2021
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2021
1	Infantile Hypercalcemia 01/2021
1	Essential Hypertension 01/2020
1	Atherosclerosis 01/2020
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2020

2	Biological ProductsIBA 04/2022 - 01/2022
2	Vitamin D3 24-HydroxylaseIBA 01/2021 - 01/2021
1	Calcineurin InhibitorsIBA 04/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2022
1	eculizumab FDA Link 04/2022
1	Azathioprine (Imuran)FDA LinkGeneric 04/2022
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 04/2022
1	Tacrolimus (Prograf)FDA LinkGeneric 04/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2022
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 04/2022
1	Rituximab (Mabthera)FDA Link 04/2022
1	Abatacept (Orencia)FDA Link 04/2022
1	Biomarkers (Surrogate Marker)IBA 10/2021
1	CopperIBA 10/2021
1	Fatty Acid-Binding ProteinsIBA 10/2021
1	Uric Acid (Urate)IBA 01/2021
1	Vitamin D FDA LinkGeneric 01/2021
1	Cholecalciferol (Vitamin D3)FDA Link 01/2021
1	hydroxide ionIBA 01/2021
1	Matrix Metalloproteinases (MMPs)IBA 01/2020
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2020
1	LipidsIBA 01/2020
1	Tissue Inhibitor of Metalloproteinase-2IBA 01/2020

1	Therapeutics 04/2022
1	Transcranial Direct Current Stimulation 01/2022
1	Kidney Transplantation 01/2021